Joint Pressure, Volume and Alignment in Development of AOA: Indications for Orthobiologics and Surgeons
Journal Title: Journal of Regenerative Biology and Medicine - Year 2019, Vol 1, Issue 2
Abstract
To fix and prevent, not ‘manage’ Osteoarthritis OA in the lower limb, should be the collective ‘Holy Grail’ with or without Orthobiologics OB. Lateral Ankle Sprain LAS, Chronic Ankle Instability CAI, and Ankle Osteoarthritis AOA create asymmetry which alters the biomechanics of the entire lower limb, so by better addressing AOA, we can probably do more than just impact the multi-billion dollar annual costs of AOA. It would seem we have advanced, if not futuristic Surgical techniques and Orthobiologic technology, so what is missing? The short answer is Medical Intent MI. Devices and methods used in rehabilitation need MI intent to enable and stimulate repair. The world is changing and Morals Ethics and the human costs, are being counted. CTE concussion is just the tip of the iceberg for cumulative trauma injuries, in cost and prevalence, and class actions seek to defend and enforce people’s rights to safety, either in the workplace, as in professional sport, or in medical outcomes. The significant yet hidden role of the subtalar joint as a ‘Safety Valve’ was first noted by Albert Ferguson in 1972, yet today the contradictions in rehabilitation and injury prevention devices that restrict the STJ, remain commonplace. It is also necessary to consider what has changed inside the synovial capsule before and after lateral ligament injury, such as pressure, joint alignment, and space, so we can better understand and design for restoration of homeostasis. This paper will examine factors, causes, and interventions that may be inadvertently restricting or preventing Orthobiologics' effectiveness in the human ankle from a Translational Medicine perspective and an engineering bias.
Authors and Affiliations
Craig J Hubbard*
Keywords
Related Articles
- EP ID EP707314
- DOI https://doi.org/10.37191/Mapsci-2582-385X-1(2)-011
- Views 90
- Downloads 0
First-level Neurocognitive Screening Tests and their Application
In June 2021, the Food and Drug Administration approved Aducanumab for the treatment of Alzheimer’s disease – the most common cause of dementia worldwide [1]. This drug is a monoclonal antibody that would be cause amylo...
Allogenic Human Umbilical Cord Derived Mesenchymal Stem Cells for Managing Knee Osteoarthritis in Human - A Clinical Trial
Introduction: Human Mesenchymal Stem Cell has been scientifically accepted as a method of managing Osteoarthritis in the Human knee. They can be derived from Autologous Bone Marrow, Adipose Tissue, and less commonly Syno...
Regeneration of Nerves Using Stem Cells to Cure Autism: Highly Sophisticated Method to Normalise Life
Autism disorder has complex and heterogeneous neurodevelopment pathologies with immune system dysfunction. Autism basically deprives one’s communication and social skills including immune abnormalities and neural hypoper...
Neurologic Manifestations of COVID-19 Disease in Children and Adults
SARS-CoV-2 has kept the world on tenterhooks for half a year. In this short time, millions of data and clinical findings have been collected, the amount of which astonishes even the scientific community. But the majority...
Editor Note- Journal of Regenerative Biology and Medicine Volume 3 Issue 2
As a Vascular Surgeon with more than 18 years of experience, I have been dealing, as most of my colleagues, with maybe the most demanding vascular condition, the Peripheral Arterial Disease (PAD). The increasing developm...